Skip to main content

Case information

Conduct a refined search of the Supreme Court of Canada database to obtain details on the status of a matter before the Court.


33874

Her Majesty the Queen v. GlaxoSmithKline Inc.

(Federal) (Civil) (By Leave)

(Sealing order)

Docket

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

List of proceedings
Date Proceeding Filed By
(if applicable)
2013-11-07 Appeal closed
2013-11-07 Certificate of taxation issued to, Patricia J. Wilson
2013-11-07 Decision on the bill of costs, (the amount claimed by Her Majesty the Queen was offset in the amount allowed to GlaxoSmithKline Inc.), in the amount of $10,842.11, DeRg
2013-11-07 Submission of the bill of costs, (both bills of costs), DeRg
2013-11-07 Order on motion to extend time, (by the DEPUTY REGISTRAR)
2013-11-07 Decision on motion to extend time, to serve and file its notice of taxation and bill of costs to May 14, 2013, DeRg, UPON APPLICATION on behalf of the appellant/respondent on cross-appeal for an order extending the time within which to serve and file its notice of taxation and bill of costs to May 14, 2013;
AND THE MATERIAL FILED having been read;
IT IS HEREBY ORDERED THAT:
The motion is granted.
Granted
2013-11-07 Submission of motion to extend time, DeRg
2013-06-03 Response to motion to extend time, (Letter Form), from Sharon Ford by fax, re: does not oppose the motion for extension of time, Completed on: 2013-06-03 GlaxoSmithKline Inc.
2013-05-24 Motion to extend time, (Letter Form), to file a notice of taxation and bill of costs, Completed on: 2013-05-24 Her Majesty the Queen
2013-05-21 Reply to the bill of costs, (filed by GlaxoSmithKline Inc.), Completed on: 2013-05-21 GlaxoSmithKline Inc.
2013-05-14 Bill of costs, on the cross-appeal and on the application for leave to cross-appeal (included in the response to the bill of costs filed by GlaxoSmithKline Inc.) (motion for extension of time filed on May 24/13), Completed on: 2013-05-14 Her Majesty the Queen
2013-05-14 Response to the bill of costs, (notice of taxation and bill of costs on the cross-appeal and application for leave to cross-appeal included in the response), Completed on: 2013-05-14 Her Majesty the Queen
2013-05-10 Record returned to the Registrar of the Court of Appeal, 2 boxes
2013-05-06 Bill of costs, (Book Form), Completed on: 2013-05-06 GlaxoSmithKline Inc.
2012-10-19 Formal judgment sent to the registrar of the court of appeal and all parties
2012-10-19 Judgment on appeal and notice of deposit of judgment sent to all parties
2012-10-18 Judgment on the appeal rendered, CJ De Abe Ro Cro Mo Ka, The appeal from the judgment of the Federal Court of Appeal, Number A-345-08, 2010 FCA 201, dated July 26, 2010, heard on January 13, 2012, is dismissed with costs throughout. The cross-appeal is dismissed with costs in this Court. The matter is remitted to the Tax Court for redetermination.
Dismissed, costs in this Court and courts below
2012-05-24 Appeal court record, 2 boxes
2012-01-31 Transcript received, (65 pages)
2012-01-13 Judgment reserved OR rendered with reasons to follow
2012-01-13 Hearing of the appeal, 2012-01-13, CJ De Abe Ro Cro Mo Ka
Judgment reserved
2012-01-13 General proceeding, Form re: Webcast Her Majesty the Queen
2012-01-13 Acknowledgement and consent for video taping of proceedings, All parties consented
2012-01-13 Respondent's condensed book, Rec'd in Court GlaxoSmithKline Inc.
2012-01-13 Appellant's condensed book, rec'd in Court Her Majesty the Queen
2012-01-12 Correspondence received from, Patricia Wilson rec'd by e-mail re: request live webcasting GlaxoSmithKline Inc.
2012-01-04 Correspondence received from, Mr. Noble re: Supplemental Authorities and consent (sent to the judges Jan. 6/12) GlaxoSmithKline Inc.
2012-01-04 Supplemental document, (Authorities) (sent to the judges Jan. 6/12), Completed on: 2012-01-04 Her Majesty the Queen
2011-12-22 Supplemental document, Supplementary record, Completed on: 2011-12-22 GlaxoSmithKline Inc.
2011-12-22 Correspondence received from, Wendy Burnham by fax, re.: request for reserved seats at the hearing Her Majesty the Queen
2011-12-22 Notice of appearance, Wendy Burnham, Eric Noble and Karen Janke will be present at the hearing. Her Majesty the Queen
2011-12-20 Notice of appearance, Al Meghji, Joseph M. Steiner, Amanda Heale and Pooja Samtani will be appearing GlaxoSmithKline Inc.
2011-12-20 Correspondence received from, Osler by fax, re.: request for reserved seats at the hearing GlaxoSmithKline Inc.
2011-12-08 Notice of hearing sent to parties
2011-12-07 Appeal hearing scheduled, 2012-01-13
Judgment reserved
2011-10-25 Order on motion to seal, (BY THE REGISTRAR)
2011-10-25 Decision on motion to seal, Reg, UPON APPLICATION by counsel on behalf of the respondent for an order sealing the unredacted version of the respondent's factum;
AND HAVING READ the material filed;
IT IS HEREBY ORDERED THAT:
1) The motion is granted.
2) The sealed unredacted version of the respondent's factum will only be made available to counsel for the appellant, counsel for the respondent in this Court and the Courts below, Ottawa agents, members of this Court, Court staff and other persons as the parties may, in writing, agree or as this Court may further order
Granted
2011-10-25 Submission of motion to seal, Reg
2011-09-20 Appeal perfected for hearing
2011-09-13 Correspondence received from, (Letter Form), from P. Olsen, dated September 13, 2011 re: sealing orders from the Tax Court GlaxoSmithKline Inc.
2011-09-13 Appellant's book of authorities - cross appeal, Included in Respondent's Authorities, Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Appellant's record - cross appeal, Included in Respondent's Record GlaxoSmithKline Inc.
2011-09-13 Appellant's factum - cross appeal, Included in respondent's factum, Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Respondent's record, (Vol. 1 to 3, volume 3 is SEALED), Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Respondent's book of authorities, (Vol. 1 and 3), Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Respondent's factum, (SEALED + 2 redacted version) - Motion to seal rec'd Sept. 13/11 - cross-appeal included, Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Motion to seal, Bookform, Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-07-28 Order on motion to seal, (BY THE REGISTRAR)
2011-07-28 Decision on motion to seal, Reg, UPON APPLICATION by counsel on behalf of the appellant for an order sealing the unredacted version of the appellant's factum;
AND HAVING READ the material filed;
IT IS HEREBY ORDERED THAT:
1) The motion is granted.
2) The sealed unredacted version of the appellant's factum will only be made available to counsel for the appellant, counsel for the respondent, Ottawa agents, members of this Court, Court staff and other persons as the parties may, in writing, agree or as this Court may further order
Granted
2011-07-28 Submission of motion to seal, Reg
2011-07-25 Response to motion to seal, (Letter Form), from Patricia J. Wilson dated July 25/11, Completed on: 2011-07-25 GlaxoSmithKline Inc.
2011-07-21 Letter advising the parties of tentative hearing date and filing deadlines (Leave granted)
2011-07-19 Appellant's book of authorities, Completed on: 2011-07-19 Her Majesty the Queen
2011-07-19 Appellant's record, Volumes VII & VIII are SEALED (8 volumes), Completed on: 2011-07-19 Her Majesty the Queen
2011-07-19 Appellant's factum, SEALED (3 redacted copies filed), Completed on: 2011-07-19 Her Majesty the Queen
2011-07-19 Motion to seal, the unredacted version of the appellant's factum, Completed on: 2011-07-19 Her Majesty the Queen
2011-04-26 Notice of appeal, Completed on: 2011-04-26 Her Majesty the Queen
2011-03-25 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2011-03-25 Judgment on leave sent to the parties
2011-03-24 Judgment of the Court on the application for leave to appeal, The applications for leave to appeal and for leave to cross-appeal from the judgment of the Federal Court of Appeal, Number A-345-08, 2010 FCA 201, dated July 26, 2010, are granted with costs in the cause. Each party shall be restricted to one factum of 40 pages to address both the appeal and the cross-appeal.
Granted, with costs in the cause
2011-03-24 Judgment of the Court on the application for leave to cross-appeal
Granted, with costs in the cause
2010-12-06 All materials on application for leave submitted to the Judges, Bi F Ro
2010-12-06 All material on the application for leave to cross-appeal submitted to the Judges, Bi F Ro
2010-11-26 Reply to the memorandum in response to the argument on cross-appeal, Completed on: 2010-11-26 GlaxoSmithKline Inc.
2010-11-19 Memorandum of argument in response to the cross-appeal, Completed on: 2010-11-19 Her Majesty the Queen
2010-11-01 Applicant's reply to respondent's argument, Completed on: 2010-11-01 Her Majesty the Queen
2010-10-22 Application for leave to cross-appeal, Included in the response, Completed on: 2010-10-22 GlaxoSmithKline Inc.
2010-10-22 Respondent's response on the application for leave to appeal, Completed on: 2010-10-22 GlaxoSmithKline Inc.
2010-09-29 Letter acknowledging receipt of a complete application for leave to appeal
2010-09-29 Application for leave to appeal, (4 volumes), Completed on: 2010-09-29 Her Majesty the Queen

Parties

Please note that in the case of closed files, the “Status” column reflects the status of the parties at the time of the proceedings. For more information about the proceedings and about the dates when the file was open, please consult the docket of the case in question.

Main parties

Main parties - Appellants
Name Role Status
Her Majesty the Queen Appellant / Respondent on cross-appeal Active

v.

Main parties - Respondents
Name Role Status
GlaxoSmithKline Inc. Respondent / Appellant on cross-appeal Active

Counsel

Party: Her Majesty the Queen

Counsel
Wendy Burnham
Eric Noble
Karen Janke-Curliss
Attorney General of Canada
234 Wellington Street
Room 843, Bank of Canada Building, East Tower
Ottawa, Ontario
K1A 0H8
Telephone: (613) 957-4820
FAX: (613) 941-2293
Agent
Christopher M. Rupar
Attorney General of Canada
50 O'Connor Street, Suite 50, Room 557
Ottawa, Ontario
K1P 6L2
Telephone: (613) 670-6290
FAX: (613) 954-1920
Email: christopher.rupar@justice.gc.ca

Party: GlaxoSmithKline Inc.

Counsel
Al Meghji
Joseph M. Steiner
Amanda Heale
Pooja Samtani
Osler, Hoskin & Harcourt LLP
P. O. Box 50
1 First Canadian Place
Toronto, Ontario
M5X 1B8
Telephone: (416) 862-5677
FAX: (416) 862-6666
Email: ameghji@osler.com
Agent
Patricia J. Wilson
Osler, Hoskin & Harcourt LLP
340 Albert Street
Suite 1900
Ottawa, Ontario
K1R 7Y6
Telephone: (613) 787-1009
FAX: (613) 235-2867
Email: pwilson@osler.com

Summary

Keywords

None.

Summary

Case summaries are prepared by the Office of the Registrar of the Supreme Court of Canada (Law Branch). Please note that summaries are not provided to the Judges of the Court. They are placed on the Court file and website for information purposes only.


Taxation – Income tax – Assessment –Transfer prices - Appeals - Minister of National Revenue reassessing taxpayer by increasing its income on basis that taxpayer had overpaid non-arm’s length supplier for purchase of drug ingredient – Whether identification of transaction which is subject of transfer price analysis is limited by bona fide legal arrangements of taxpayer - Whether transfer prices in independent transactions between Canadian taxpayer and different entities of multinational group should be assessed separately or bundled together - Whether when conducting transfer pricing analysis in Canada, arm’s length standard has been displaced by “reasonable business person” test – Whether Federal Court of Appeal erred in returning matter to Tax Court of Canada for rehearing - Income Tax Act, R.S.C. 1985 (5th Supp.), c. 1, s. 69(2).

The Minister of National Revenue reassessed the respondent taxpayer by increasing its income on the basis that the taxpayer had overpaid its non-arm’s length supplier for the purchase of ranitidine, the active pharmaceutical ingredient in a drug marketed by the taxpayer in Canada. According to the Minister, a reasonable amount for the taxpayer to have paid for ranitidine was the price paid by other pharmaceutical companies that were selling generic versions of the drug. The Tax Court of Canada upheld the reassessments except for minor upward adjustment to the price paid by the taxpayer. The Federal Court of Appeal set aside the Tax Court decision and returned the matter for rehearing.



Lower court rulings

May 30, 2008
Tax Court of Canada

98-712(IT)G, 2008 TCC 324

Appeals from assessments allowed

July 26, 2010
Federal Court of Appeal

A-345-08, 2010 FCA 201

Appeal allowed, Tax Court's decision set aside and matter returned for rehearing

Memorandums of argument on application for leave to appeal

The memorandums of argument on an application for leave to appeal will be posted here 30 days after leave to appeal has been granted unless they contain personal information, information that is subject to a publication ban, or any other information that is not part of the public record. You may also obtain copies of the memorandum by filing out the Request for Court records form or by contacting the Court’s Records Centre either by email at records-dossiers@scc-csc.ca or by telephone at 613‑996‑7933 or at 1‑888‑551‑1185.

If you have questions about a memorandum of argument or want to use a memorandum of argument, please contact the author of the memorandum of argument directly. Their name appears at the end of the memorandum of argument. The contact information for counsel is found in the “Counsel” tab of this page.

Downloadable PDFs

Not available

Factums on appeal

The factums of the appellant, the respondent and the intervener will be posted here at least 2 weeks before the hearing unless they contain personal information, information that is subject to a publication ban, or any other information that is not part of the public record. You may also obtain copies of factums by filling out the Request for Court records form or by contacting the Court’s Records Centre either by email at records-dossiers@scc-csc.ca or by telephone at 613‑996‑7933 or at 1‑888‑551‑1185.

If you have questions about a factum or want permission to use a factum, please contact the author of the factum directly. Their contact information appears on the first page of each factum.

Downloadable PDFs

Not available

Webcasts

Select format
Select language
Date modified: 2025-02-27